India, Oct. 15 -- On Thursday, Jyong Biotech Ltd. (MENS), a Taiwan-based biotechnology company focused on plant-derived therapeutics, announced plans to establish a potential pharmaceutical manufacturing facility and U.S. operations center in Texas. Shares were unchanged.
The proposed facility is intended to support the company's U.S. operations and potential future commercialization of its investigational drug candidates, subject to regulatory approval.
Jyong Biotech has submitted a facility and operations plan to Texas state authorities and is preparing to begin formal communications with relevant government agencies regarding the required procedures.
The company selected Texas after evaluating factors including land costs, corporate t...